SEC Form 5 · accession 0001570523-18-000019
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 27, 2016 | P | 10,000 | $0.10 | A | 20,800,359 | D | |
| Common stock | Sep 27, 2016 | P | 10,000 | $0.105 | A | 20,800,359 | D | |
| Common stock | Sep 27, 2016 | P | 10,000 | $0.11 | A | 20,800,359 | D | |
| Common stock | Sep 28, 2016 | P | 5,000 | $0.0999 | A | 20,800,359 | D | |
| Common stock | Sep 28, 2016 | P | 1,000 | $0.0998 | A | 20,800,359 | D | |
| Common stock | Oct 3, 2016 | P | 10,000 | $0.0889 | A | 20,800,359 | D | |
| Common stock | Oct 4, 2016 | P | 21,400 | $0.0853 | A | 20,800,359 | D | |
| Common stock | Oct 4, 2016 | P | 3,600 | $0.0589 | A | 20,800,359 | D | |
| Common stock | Oct 4, 2016 | P | 30,000 | $0.08 | A | 20,800,359 | D | |
| Common stock | Oct 18, 2016 | P | 1,000 | $0.0779 | A | 20,800,359 | D | |
| Common stock | Oct 24, 2016 | P | 1,250 | $0.0748 | A | 20,800,359 | D | |
| Common stock | Oct 24, 2016 | P | 18,750 | $0.078 | A | 20,800,359 | D | |
| Common stock | Oct 24, 2016 | P | 20,000 | $0.0779 | A | 20,800,359 | D | |
| Common stock | Oct 25, 2016 | P | 1,250 | $0.0724 | A | 20,800,359 | D | |
| Common stock | Oct 25, 2016 | P | 1,250 | $0.0724 | A | 20,800,359 | D | |
| Common stock | Oct 25, 2016 | P | 1,250 | $0.0724 | A | 20,800,359 | D | |
| Common stock | Oct 25, 2016 | P | 14,200 | $0.079 | A | 20,800,359 | D | |
| Common stock | Oct 25, 2016 | P | 2,050 | $0.08 | A | 20,800,359 | D | |
| Common stock | Oct 27, 2016 | P | 15,000 | $0.0749 | A | 20,800,359 | D | |
| Common stock | Oct 31, 2016 | P | 10,000 | $0.0718 | A | 20,800,359 | D | |
| Common stock | Nov 2, 2016 | P | 1,250 | $0.0652 | A | 20,800,359 | D | |
| Common stock | Nov 2, 2016 | P | 3,750 | $0.0699 | A | 20,800,359 | D | |
| Common stock | Nov 3, 2016 | P | 5,000 | $0.078 | A | 20,800,359 | D | |
| Common stock | Nov 7, 2016 | P | 1,100 | $0.078 | A | 20,800,359 | D | |
| Common stock | Nov 14, 2016 | P | 1,000 | $0.0566 | A | 20,800,359 | D | |
| Common stock | Nov 15, 2016 | P | 15,000 | $0.0719 | A | 20,800,359 | D | |
| Common stock | Nov 16, 2016 | P | 1,000 | $0.0785 | A | 20,800,359 | D | |
| Common stock | Nov 17, 2016 | P | 1,000 | $0.08 | A | 20,800,359 | D | |
| Common stock | Nov 21, 2016 | P | 1,000 | $0.0646 | A | 20,800,359 | D | |
| Common stock | Nov 21, 2016 | P | 500 | $0.0622 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 15 of 16 submissions.